Delivery Order SPE2DB24D2012-SPE2DB24FBVSL

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx medication doses to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, and has a ceiling value of $4,565.85. The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This federal contract award is for the delivery of Cosentyx, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,131.76 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of September 20, 2023 and does not include any set-aside designations, indicating full and open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product Cosentyx (300mg dose) to the U.S. government. The single-award Indefinite Delivery Contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical...
This federal contract award is for the delivery of Cosentyx, a specialty medication, to the Defense Logistics Agency (DLA). The contract, valued at $6,234.28, has a period of performance through January 28, 2025. It was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx, a specialty medication. The contract has a ceiling value of $3,149.12 and an ultimate completion date of December 6, 2024. It is a delivery order contract with a firm fixed price pricing structure. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $36,279.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Cosentyx, a medication used to treat various medical conditions. The contract has a firm fixed price and an ultimate completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx, a specialty medication, at a ceiling value of $14,410.67. The contract has an ultimate completion date of December 19, 2023 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award is for the delivery of Cosentyx 300 mg dose injectable medication to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,485.09 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 24, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $1,574.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Cosentyx, a specialty pharmaceutical product for the treatment of various medical conditions. The award has a firm fixed price and an ultimate completion date of December 12, 2024. The contract is not associated with any set-aside designation,...
This federal contract award, valued at $11,060.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Cosentyx, a medication used to treat certain autoimmune conditions. The contract is a firm fixed-price delivery order with a completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D2012
    Indefinite Delivery Contract
  • SPE2DB24D2012-SPE2DB24FBVSL
    Delivery Order

This federal contract award is for the delivery of Cosentyx, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a ceiling value of $14,203.88 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract does not have a set-aside designation, and the ultimate completion date is September 13, 2024. AmerisourceBergen Drug Corp has been awarded numerous federal contracts by various defense and civilian agencies to supply a wide range of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies, in support of military treatment programs and federal healthcare providers.

Generated 12/12/24, 10:35 AM